If you have trouble reading this e-mail, please click here |
January 31, 2012 Afternoon Update |
TOP NEWSGingrich Stays Defiant in Face of Polls as Florida VotesBy TRIP GABRIELFlorida Republicans began casting ballots Tuesday, as Newt Gingrich, who lagged far behind in recent polls, tried to stop Mitt Romney's march to the party's presidential nomination. The CaucusRomney's Fight to Win Comes at a Cost, Polls ShowBy MICHAEL D. SHEARPolls suggest that Mitt Romney's standing among many voters has slipped during a bruising nominating fight. Russia Stands in the Way of U.N. Call for Assad to Step DownBy NEIL MacFARQUHARArab and Western states confronted Russia on Tuesday over its refusal to condemn the Syrian government for its violent suppression of popular protests. Budget Deficit Tops $1 Trillion, but Is Falling, Report SaysBy ROBERT PEAR and JOHN H. CUSHMAN Jr.Unless Congress passes new legislation changing the course on spending or taxation - changes that are a distinct possibility - projected deficits would "drop markedly," a report says. Intelligence Chief Sees Al Qaeda Likely to Continue FragmentingBy ERIC SCHMITTThe assessment by James R. Clapper, the director of national intelligence, added new detail to similar analyses by American counterterrorism officials in recent months. |
MultimediaOpinion |
BUSINESSRare Earth Metal Refinery Nears ApprovalBy KEITH BRADSHERDespite street demonstrations over radiation worries, regulatory challenges and the withdrawal of a supplier worried about safety, the opening of a plant in Malaysia appears imminent. Home Prices Decline AgainBy MOTOKO RICHSingle-family home prices in the United States fell in November, a closely watched survey showed, putting the average price down to a level last seen in 2003. Hopes Now Shift to E.C.B. in Finalizing Greek BailoutBy STEPHEN CASTLE and JACK EWINGOfficials say a deal involving the central bank's holdings of Greek bonds could bridge a crucial funding gap and clear the way for the next bailout. Higher Oil Prices Lift Profit at ExxonBy CLIFFORD KRAUSSThe world's largest publicly traded oil company reported net income of $9.4 billion for the quarter, up from $9.25 billion the year before. F.D.A. Approves Cystic Fibrosis DrugBy ANDREW POLLACKThe Food and Drug Administration called Kalydeco a "breakthrough therapy" because it treats the underlying cause of the genetic disease, rather than just the symptoms. |
About This E-MailYou received this message because you signed up for NYTimes.com's Afternoon Update newsletter. As a member of the TRUSTe privacy program, we are committed to protecting your privacy. |
ليست هناك تعليقات:
إرسال تعليق